Whitefort Capital Management, LP In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Whitefort Capital Management, LP reported 18 stock positions worth $391.6 million . Its top holding was Arbutus Biopharma (ABUS) at 19.4% of the portfolio, followed by Roivant Sciences (ROIV, 9.2% ) and Joyy Inc.-ADR (JOYY, 8.8% ). Compared with Q1 2026, it opened 2 new positions, sold out of 1, added to 6 and reduced 4. The biggest buy was Nextnav (NN, shares +2531% ) and the biggest sale an exit from Uniqure (QURE).
Location NEW YORK, NY
CIK 0001884931
Portfolio Value $391.6M (Q2 2026) Holdings 18 stocks · $391.6M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2026 ABUS Arbutus Biopharma Corp. 15,794,261 $75.8M Add +5.8% ROIV Roivant Sciences Ltd. 1,019,000 $36.1M Reduce -28.2% JOYY Joyy Inc.-ADR 524,944 $34.6M No change BALY Bally's Corp. 2,408,063 $33.0M No change GNW Genworth Financial Inc. 3,130,301 $29.6M No change NN Nextnav Inc. 1,596,116 $28.5M Add +2531.5% OABI Omniab Inc. 10,248,658 $25.2M Reduce -27.9% ZD Ziff Davis Inc. 418,389 $21.9M New TDAY USA Today Co. Inc. 2,004,833 $17.1M Reduce -35.8% CDZI Cadiz Inc. 3,986,822 $16.7M No change SGRY Surgery Partners Inc. 901,332 $15.1M Reduce -1.1% PUBM Pubmatic Inc. Class A 1,110,656 $14.6M Add +61.0% VATE Innovate Corp. 743,000 $13.9M No change SOC Sable Offshore Corp. 3,720,063 $11.5M Add +140.8% OPK Opko Health Inc. 4,511,412 $6.8M Add +6.1% DDI Doubledown Interactive -ADR 546,172 $6.3M New TEAD Teads Holding Co. 4,609,163 $3.5M Add +27.7% KG Kestrel Group 160,916 $1.4M No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $14.1M (not counted above) Total filed on the 13F, all lines: $405.7M.
Portfolio Sells Q1 2026 → Q2 2026 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2026 % Of Portfolio Change To Portfolio ▲ QURE Uniqure NV Sold out 0.00% −3.40 ROIV Roivant Sciences Ltd. Reduce -28.2% 9.21% −3.20 TDAY USA Today Co. Inc. Reduce -35.8% 4.38% −2.58 OABI Omniab Inc. Reduce -27.9% 6.44% −0.61 SGRY Surgery Partners Inc. Reduce -1.1% 3.87% +0.44
Portfolio Buys Q1 2026 → Q2 2026 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2026 % Of Portfolio Change To Portfolio ▼ NN Nextnav Inc. Add +2531.5% 7.27% +6.96 ZD Ziff Davis Inc. New 5.59% +5.59 PUBM Pubmatic Inc. Class A Add +61.0% 3.72% +1.94 DDI Doubledown Interactive -ADR New 1.60% +1.60 OPK Opko Health Inc. Add +6.1% 1.73% +0.20 TEAD Teads Holding Co. Add +27.7% 0.90% +0.15 ABUS Arbutus Biopharma Corp. Add +5.8% 19.36% −1.86 SOC Sable Offshore Corp. Add +140.8% 2.93% −5.13
Options Activity Q1 2026 → Q2 2026 Security Type Change vs Q1 2026 Underlying Shares Value ▼ GLD SPDR Gold Shares call Sold out 24,400 $10.5Mbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q1 2026 → Q2 2026 Security Class Change vs Q1 2026 Shares / Principal Value ▼ NNAVW Nextnav Inc. *W EXP 99/99/999 Sold out 47,264 $299Kbefore exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 18 $391.6M ABUS, ROIV, JOYY, BALY, GNW Q1 2026 17 $316.6M ABUS, ROIV, JOYY, SOC, GNW Q4 2025 15 $317.7M ABUS, ROIV, BALY, OABI, JOYY Q3 2025 14 $287.4M ABUS, ROIV, GNW, JOYY, OABI Q2 2025 Amended 14 $239.0M JOYY, ROIV, ABUS, GNW, OABI Q1 2025 11 $185.2M ABUS, ROIV, JOYY, GNW, LQDA Q4 2024 13 $191.5M ABUS, ROIV, LQDA, GNW, CDZI Q3 2024 13 $201.5M ABUS, EDR, ROIV, JOYY, GNW Q2 2024 16 $143.4M ABUS, ROIV, NN, GNW, GSL Q1 2024 13 $153.2M GSL, ABUS, ROIV, LSXMK, GNW